Boothbay Fund Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,816
| Closed | -$433K | – | 1753 |
|
|
2023
Q2 | $433K | Buy |
10,816
+5,061
| +88% | +$203K | 0.01% | 982 |
|
|
2023
Q1 | $235K | Buy |
+5,755
| New | +$235K | ﹤0.01% | 1423 |
|
|
2020
Q3 | – | Sell |
-7,110
| Closed | -$373K | – | 1055 |
|
|
2020
Q2 | $373K | Buy |
+7,110
| New | +$373K | 0.03% | 543 |
|
|
2017
Q3 | – | Sell |
-4,218
| Closed | -$201K | – | 660 |
|
|
2017
Q2 | $201K | Buy |
+4,218
| New | +$201K | 0.04% | 484 |
|
|
2017
Q1 | – | Sell |
-10,078
| Closed | -$1.47K | – | 811 |
|
|
2016
Q4 | $1.47K | Buy |
+10,078
| New | +$1.47K | 0.34% | 29 |
|